Literature DB >> 27366588

Igg Subclasses Targeting the Flagella of Salmonella enterica Serovar Typhimurium Can Mediate Phagocytosis and Bacterial Killing.

Yun Shan Goh1, Kathryn L Armour2, Michael R Clark2, Andrew J Grant1, Pietro Mastroeni1.   

Abstract

Invasive non-typhoidal Salmonella are a common cause of invasive disease in immuno-compromised individuals and in children. Multi-drug resistance poses challenges to disease control, with a critical need for effective vaccines. Flagellin is an attractive vaccine candidate due to surface exposure and high epitope copy number, but its potential as a target for opsonophacytic antibodies is unclear. We examined the effect of targeting flagella with different classes of IgG on the interaction between Salmonella Typhimurium and a human phagocyte-like cell line, THP-1. We tagged the FliC flagellar protein with a foreign CD52 mimotope (TSSPSAD) and bacteria were opsonized with a panel of humanised CD52 antibodies with the same antigen-binding V-region, but different constant regions. We found that IgG binding to flagella increases bacterial phagocytosis and reduces viable intracellular bacterial numbers. Opsonisation with IgG3, followed by IgG1, IgG4, and IgG2, resulted in the highest level of bacterial uptake and in the highest reduction in the intracellular load of viable bacteria. Taken together, our data provide proof-of-principle evidence that targeting flagella with antibodies can increase the antibacterial function of host cells, with IgG3 being the most potent subclass. These data will assist the rational design of urgently needed, optimised vaccines against iNTS disease.

Entities:  

Keywords:  Antibody; Flagella; IgG subclasses; Opsonisation; Phagocytosis

Year:  2016        PMID: 27366588      PMCID: PMC4924609          DOI: 10.4172/2157-7560.1000322

Source DB:  PubMed          Journal:  J Vaccines Vaccin


  53 in total

1.  Membrane ruffling and invasion of human and avian cell lines is reduced for aflagellate mutants of Salmonella enterica serotype Enteritidis.

Authors:  Roberto M La Ragione; William A Cooley; Philippe Velge; Mark A Jepson; Martin J Woodward
Journal:  Int J Med Microbiol       Date:  2003-08       Impact factor: 3.473

Review 2.  Human antibody effector function.

Authors:  D R Burton; J M Woof
Journal:  Adv Immunol       Date:  1992       Impact factor: 3.543

Review 3.  Nontyphoidal salmonellosis in Africa.

Authors:  Stephen M Graham
Journal:  Curr Opin Infect Dis       Date:  2010-10       Impact factor: 4.915

Review 4.  Spread of Salmonella enterica in the body during systemic infection: unravelling host and pathogen determinants.

Authors:  Pietro Mastroeni; Andrew J Grant
Journal:  Expert Rev Mol Med       Date:  2011-04-11       Impact factor: 5.600

5.  Single-copy green fluorescent protein gene fusions allow accurate measurement of Salmonella gene expression in vitro and during infection of mammalian cells.

Authors:  Isabelle Hautefort; Maria José Proença; Jay C D Hinton
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

6.  CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.

Authors:  Catarina J M Braga; Liliana M Massis; Maria E Sbrogio-Almeida; Bruna C G Alencar; Daniel Y Bargieri; Silvia B Boscardin; Maurício M Rodrigues; Luís C S Ferreira
Journal:  Vaccine       Date:  2009-11-21       Impact factor: 3.641

7.  Effect of immune serum and role of individual Fcgamma receptors on the intracellular distribution and survival of Salmonella enterica serovar Typhimurium in murine macrophages.

Authors:  Hazel Uppington; Nathalie Menager; Peter Boross; James Wood; Mark Sheppard; Sjef Verbeek; Pietro Mastroeni
Journal:  Immunology       Date:  2006-07-12       Impact factor: 7.397

8.  Differing burden and epidemiology of non-Typhi Salmonella bacteremia in rural and urban Kenya, 2006-2009.

Authors:  Collins Tabu; Robert F Breiman; Benjamin Ochieng; Barrack Aura; Leonard Cosmas; Allan Audi; Beatrice Olack; Godfrey Bigogo; Juliette R Ongus; Patricia Fields; Eric Mintz; Deron Burton; Joe Oundo; Daniel R Feikin
Journal:  PLoS One       Date:  2012-02-21       Impact factor: 3.240

9.  Cell-associated flagella enhance the protection conferred by mucosally-administered attenuated Salmonella Paratyphi A vaccines.

Authors:  Orit Gat; James E Galen; Sharon Tennant; Raphael Simon; William C Blackwelder; David J Silverman; Marcela F Pasetti; Myron M Levine
Journal:  PLoS Negl Trop Dis       Date:  2011-11-01

10.  Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella.

Authors:  Yun Shan Goh; Simon Clare; Francesca Micoli; Allan Saul; Pietro Mastroeni; Calman A MacLennan
Journal:  Infect Immun       Date:  2015-07-13       Impact factor: 3.441

View more
  7 in total

Review 1.  Antibodies and Protection in Systemic Salmonella Infections: Do We Still Have More Questions than Answers?

Authors:  Pietro Mastroeni; Omar Rossi
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  Salmonella Paratyphi A Outer Membrane Vesicles Displaying Vi Polysaccharide as a Multivalent Vaccine against Enteric Fever.

Authors:  F Micoli; P Mastroeni; G Gasperini; R Alfini; V Arato; F Mancini; M G Aruta; P Kanvatirth; D Pickard; F Necchi; A Saul; O Rossi
Journal:  Infect Immun       Date:  2021-03-17       Impact factor: 3.441

3.  Identification of linear epitopes on the flagellar proteins of Clostridioides difficile.

Authors:  A Razim; K Pacyga; P Naporowski; D Martynowski; A Szuba; A Gamian; S Górska
Journal:  Sci Rep       Date:  2021-05-11       Impact factor: 4.379

4.  The essential role of complement in antibody-mediated resistance to Salmonella.

Authors:  Omar Rossi; Chris Coward; Yun Shan Goh; Jill W C Claassens; Calman A MacLennan; Sjef J Verbeek; Pietro Mastroeni
Journal:  Immunology       Date:  2018-10-10       Impact factor: 7.397

5.  Immunogenicity and efficacy following sequential parenterally-administered doses of Salmonella Enteritidis COPS:FliC glycoconjugates in infant and adult mice.

Authors:  Scott M Baliban; Brittany Curtis; Deanna Toema; Sharon M Tennant; Myron M Levine; Marcela F Pasetti; Raphael Simon
Journal:  PLoS Negl Trop Dis       Date:  2018-05-23

6.  Maternal Antibodies Elicited by Immunization With an O- Polysaccharide Glycoconjugate Vaccine Protect Infant Mice Against Lethal Salmonella Typhimurium Infection.

Authors:  Scott M Baliban; Brittany Curtis; Mohammed N Amin; Myron Mike Levine; Marcela F Pasetti; Raphael Simon
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

Review 7.  Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases.

Authors:  Joaquin Miguel Pellegrini; Jean-Pierre Gorvel; Sylvie Mémet
Journal:  Microorganisms       Date:  2022-06-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.